Quetiapine Fumarate Tablet, Film Coated
Product Images NDC 68071-3931

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 68071-3931). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3931 9)

Pdp (68071 3931 9)
Quetiapine Fumarate 25 mg tablets label from NuCare Pharmaceuticals, Inc. The label indicates 90 film-coated tablets, circular and peach colored with 'U' and '25' debossed on opposite sides. Includes NDC 68071-3931-9, product number P1903090, and storage instructions at controlled temperature 68-77°F. Marked Rx only with standard warning to keep out of reach of children.*
FDA Label Image

Molecular Structure (9054a1a7 C7ea 4630 Be0b 2dcbe910ca94 01)

Molecular Structure (9054a1a7 C7ea 4630 Be0b 2dcbe910ca94 01)
Chemical structure of quetiapine fumarate, showing the molecular arrangement of quetiapine complexed with fumarate ions.*
FDA Label Image

Figure 1 (9054a1a7 C7ea 4630 Be0b 2dcbe910ca94 02)

Figure 1 (9054a1a7 C7ea 4630 Be0b 2dcbe910ca94 02)
A line graph depicting the proportion of patients with relapse (%) over time (weeks) up to 100 weeks. The graph compares two groups: one treated with QTP+ LIVAL (dashed line) and another with PLA+ LIVAL (solid line), showing relapse trends over the study period.*
FDA Label Image

Figure 2 (9054a1a7 C7ea 4630 Be0b 2dcbe910ca94 03)

Figure 2 (9054a1a7 C7ea 4630 Be0b 2dcbe910ca94 03)
A line graph comparing the proportion of patients with relapse over time in weeks. The graph displays two lines labeled QTP+LI/VAL and PLA+LI/VAL, showing different relapse rates over a period of approximately 70 weeks. The vertical axis represents the percentage of patients with relapse from 0 to 100%, and the horizontal axis represents time in weeks from 0 to 100.*
FDA Label Image

Logo (9054a1a7 C7ea 4630 Be0b 2dcbe910ca94 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.